SAT-220-Higher frequency of occult HCV infection in HIV/HCV coinfected patients with advanced liver disease: Post DAAs treatment observation
Sabrina Bagaglio(Vita-Salute San Raffaele University), Hamid Hasson(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University), Liviana Della Torre(Vita-Salute San Raffaele University), Emanuela Messina(Vita-Salute San Raffaele University), Riccardo Vercesi(IRCCS Ospedale San Raffaele), Alba Bigoloni, Giulia Morsica(Vita-Salute San Raffaele University), Vinci Concetta(IRCCS Ospedale San Raffaele), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Stefania Salpietro(IRCCS Ospedale San Raffaele)
Cited by 0
Related Papers
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
|The Lancet|1992|393
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173